Uncategorized
FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics’ Filspari
FDA eases REMS labeling for Travere’s Filspari, reducing liver monitoring and removing embryo-fetal toxicity rules, with FSGS approval review ongoing. read more
CrowdStrike Analysts Emphasize Long-Term Strength Of Cybersecurity Platform
Shares of CrowdStrike Holdings (CRWD) rose on upbeat Q2 results. Wedbush, Rosenblatt, Goldman Sachs, Needham, and Cantor Fitzgerald maintain Buy ratings. Latest Ratings for CRWD Date Firm Action From To Mar 2022 Barclays Maintains Overweight Mar 2022 Canaccord Genuity Maintains Buy Mar 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for CRWD View the…
Jack Daniel’s Parent Brown-Forman Keeps Outlook Steady While Flagging Market Pressures
Brown Forman Inc. stock dropped after reporting weaker-than-expected quarterly results, driven by declines in the U.S. and developed international markets. read more
What’s Going On With Tilray Stock Today?
Tilray shares rose ~5% after launching three EU-GMP medical cannabis strains in Germany and confirming renewed Nasdaq bid-price compliance. read more
What’s Going On With Ollie’s Bargain Outlet Stock On Thursday?
Ollie’s Bargain Outlet posts strong Q2 beats with higher sales, margins and guidance, while expanding store openings to 85. read more
Sharps Technology (STSS) Stock Is Up 130% Over The Past Week: What’s Going On?
Shares of Sharps Technology Inc (NASDAQ:STSS) have surged 130% over the past five trading sessions. read more
Snowflake Stock Is On Fire Thursday: Here’s Why
Snowflake Inc (NYSE:SNOW) shares are surging Thursday after the company reported better-than-expected financial results for the second quarter. Several analysts also raised price targets following the report. read more